The global in-ear monitors (IEMs) industry is set to experience substantial growth, reaching a valuation of US$ 344.7 Million in 2022 and projecting a robust CAGR of 9.0% over the forecast period. By 2032, the market is estimated to soar to an impressive US$ 749.7 Million. The surge in the number of musical concerts, live …
Category Archives: Healthcare Trends
Global Mobile Clinics Industry Predicted to Experience Significant Growth, Reaching US$ 8.1 Billion by 2032
The global mobile clinics industry is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 11.3% from 2022 to 2032, according to a recent analysis by Future Market Insights. The market is anticipated to reach a valuation of US$ 2.8 Billion by the end of 2022 and is expected to surpass …
Global Surgical Sutures Industry Set for Staggering Growth with a Projected 5.4% CAGR by 2032 | FMI
The global surgical sutures industry is on the brink of a transformative expansion, with forecasted projections revealing a robust Compound Annual Growth Rate (CAGR) of 5.4% during the period from 2022 to 2032. According to a comprehensive market analysis, the industry is expected to soar from an estimated worth of US$ 8.2 billion at the …
Global Outsourced Testing Services Industry is set to make history, achieving a substantial milestone of US$ 76.3 Billion by 2032, according to FMI
The global outsourced testing services industry is experiencing unprecedented growth, projected to be valued at US$ 36.4 billion in 2022 and expected to achieve a remarkable CAGR of 7.7%, reaching US$ 76.3 billion by 2032. These insights, highlighted in a recent analysis by Future Market Insights, underscore the industry’s robust trajectory and present a significant …
Global Retinoids Industry is poised to achieve US$ 2.5 Billion by 2032, with a 5.4% CAGR as forecasted by FMI
The global retinoids industry is poised for substantial growth, with a current valuation of US$ 1.5 Billion in 2022 and a projected surge to US$ 2.5 Billion by 2032. This growth is anticipated to occur at a steady Compound Annual Growth Rate (CAGR) of 5.4% between 2022 and 2032. Dermatologists are increasingly favoring less invasive …
Global Digital Health Industry is set to revolutionize healthcare by reaching an estimated US$ 2585.98 Billion by 2032, according to FMI
The global digital health industry, a burgeoning sector anticipated to be valued at an impressive US$ 224.24 billion in 2022, is poised for remarkable growth, projected to ascend at a Compound Annual Growth Rate (CAGR) of 27.7% from 2022 to 2032. Forecasts suggest that by the end of 2032, this industry is estimated to skyrocket …
Global Vital Signs Monitoring Devices Industry to Expand at 8% CAGR, Surpassing US$ 16 Billion by 2033 | FMI
The Global Vital Signs Monitoring Devices Industry is poised for remarkable growth, with a projected valuation of US$ 16 billion by 2033. According to Future Market Insights (FMI), the industry will showcase a robust Compound Annual Growth Rate (CAGR) of 8% from 2023 to 2033, building on an estimated market worth of US$ 7.4 billion …
Global Animal Healthcare Industry on Track for a Remarkable US$ 62.3 Billion Valuation by 2033, Fueled by 4.3% CAGR | Predicted by FMI
The Global Animal Healthcare Industry is poised for an extraordinary surge, with anticipated values reaching US$ 40.9 billion in 2023 and a remarkable US$ 62.3 billion by 2033, according to the latest forecast by Future Market Insights (FMI). This exponential growth is underpinned by a solid compound annual growth rate (CAGR) of 4.3% throughout the …
Global Herbal Medicinal Products Industry Set to Surpass $417.99 Billion by 2033, Driven by Impressive 7.7% CAGR | Reveals FMI Forecast
In a groundbreaking study conducted by Future Market Insights (FMI), the Global Herbal Medicinal Products Industry is set to embark on an extraordinary growth trajectory, with a projected valuation of US$ 199.07 billion by the year 2023. Even more astonishing is the forecast for global herbal medicine sales, expected to surge to an impressive US$ …
Global Biopharmaceutical Contract Manufacturing Industry on Track for 10.5% CAGR, Envisions US$18.7 Billion Market by 2029 | According to FMI
The Global Biopharmaceutical Contract Manufacturing Industry, valued at an estimated US$9.3 billion in 2022, is poised for a remarkable surge with a projected Compound Annual Growth Rate (CAGR) of 10.5%. Forecasts indicate that by 2029, the industry is set to hit a staggering US$18.7 billion. This unprecedented growth underscores the accelerating trend among pharmaceutical companies …